|
|
|
|
|
Azulfidine |
|
|
|
- Description - |
Azulfidine, an anti-inflammatory medicine, is prescribed for the treatment ofmild to moderate ulcerative colitis (a long-term, progressive bowel disease)and as an added treatment in severe ulcerative colitis (chronic inflammationand ulceration of the lining of large bowel and rectum, the main symptom ofwhich is bloody diarrhea). This medication isalso prescribed to decrease severe attacks of ulcerative colitis.
Azulfidine EN-tabs are prescribed for people with ulcerative colitis who cannot take theregularAzulfidine tablet because of symptoms of stomach and intestinal irritationsuch as nausea and vomiting when taking the first few doses of thedrug, or for those in whom a reduction in dosage does not lessen thestomach or intestinal side effects. The EN-tabsare also prescribed for adults and children with rheumatoid arthritis who fail to get relief fromsalicylates (such as aspirin) or other nonsteroidal anti-inflammatory drugs (such as ibuprofen). |
|
|
- Common Side Effects - |
|
Abdominal pain,anemia,bluish skin,fever,headache,hives,inflammation of the mouth,itching,lack of appetite,nausea,rash,stomach distress,vomiting |
|
|
- Possible Interactions - |
Digoxin (Lanoxin)
Folic acid (a B-complex vitamin)
|
|
|
- Manufacturer - |
|
Pfizer U.S. Pharmaceuticals Group |
|
235 East 42nd Street |
|
|
|
New York, NY 10017-5755 |
|
USA |
|
|
|
|